Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
Clinical trial NCT04501666 · COMPLETED
Trial details
- NCT number
- NCT04501666
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-11
- Primary completion
- 2022-11-11
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.